M&A Deal Summary

Ardena Acquires Catalent - Oral Solids Facility

On October 14, 2024, Ardena acquired life science company Catalent - Oral Solids Facility from Catalent

Acquisition Highlights
  • This is Ardena’s 2nd transaction in the Life Science sector.
  • This is Ardena’s 1st transaction in the United States.
  • This is Ardena’s 1st transaction in New Jersey.

M&A Deal Summary

Date 2024-10-14
Target Catalent - Oral Solids Facility
Sector Life Science
Buyer(s) Ardena
Sellers(s) Catalent
Deal Type Divestiture

Target

Catalent - Oral Solids Facility

Somerset, New Jersey, United States
Catalent's Oral Solids Facility is a Contract Development and Manufacturing Organization (CDMO).

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Ardena

Ghent, Belgium

Category Company
Founded 1994
Sector Life Science
DESCRIPTION

Ardena is a contract development and manufacturing organization (CDMO). Ardena offers an integrated, flexible service encompassing drug substance production, dosage form manufacture, clinical logistics, bioanalysis, and dossier development. Ardena was founded in 1994 and is based in Ghent, Belgium.


DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Divestiture M&A Deals 1 of 1
State: New Jersey M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2024 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-03-16 ChemConnection BV

Oss, Netherlands

ChemConnection BV is a contract manufacturer of novel active pharmaceutical ingredients (APIs) and nanomedicines. ChemConnection BV was founded in 2012 and is based in Oss, Netherlands.

Buy -

Seller(S) 1

SELLER

Catalent

Somerset, New Jersey, United States

Category Company
Founded 2007
Sector Life Science
Revenue 4.3B USD (2023)
DESCRIPTION

Catalent is a provider of solutions for drugs, biologics and consumer health products. Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, holds patents for softgel (e.g. “Liqui-Caps” and “Vegicaps”) and Zydis fast-dissolve technologies used in many popular prescription and over-the-counter medicine. Catalent was founded in 2007 and is based in Somerset, New Jersey.


DEAL STATS #
Overall 3 of 3
Sector: Life Science M&A 3 of 3
Type: Divestiture M&A Deals 3 of 3
State: New Jersey M&A 1 of 1
Country: United States M&A 3 of 3
Year: 2024 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-09 Metrics Contract Services

Greenville, North Carolina, United States

Metrics Contract Services is a full-service pharmaceutical development and manufacturing organization serving clients worldwide delivering proven scientific and operational excellence for novel oral dosage forms. Metrics provides formulation development, analytical testing, and commercial manufacturing from its single-campus facility in Greenville, North Carolina.

Buy $475M